Prot# U2971g: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II/III Study to Evaluate the Efficacy and Safety of Rituximab in Subjects with Moderate to Severe Systemic Lupus Erythematosus

Project: Research project

Project Details

StatusFinished
Effective start/end date1/20/0610/6/10

Funding

  • PPD Development (U2971g)
  • Genentech, Inc. (U2971g)